Managing a case of stroke is complex. Presence of variable sized brain infarct and heart failure is even more complex to manage. On top of this, presence of clot in the heart adds to confusion in medical management of stroke patients because of limited scientific evidences. With increasing number of stroke patients and improving diagnostic facility, it is interesting to find thrombus in ventricles of few of these patient, which otherwise were uncommon previously in our set up. We present a 64-year-old man, a case of ischemic stroke caused by left ventricular thrombus secondary to dilated cardiomyopathy and highlight the present recommendation to manage the condition.
Introduction
Stroke is sudden onset of a neurologic deficit from a vascular mechanism which may be either ischemic or hemorrhagic. Amongst various etiologies, ischemic stroke is most often due to embolic occlusion of large cerebral vessels; source of emboli may be heart, aortic arch or a more proximal arterial lesion. We present a 64-year-old man, a case of ischemic stroke caused by left ventricular thrombus secondary to dilated cardiomyopathy and highlight the present recommendation to manage the condition.
Discussion
Stroke is an increasing public health concern throughout the world; it is the second commonest cause of death and the leading cause of long-term disability worlwide. 1 The incidence of cerebrovascular disease varies in different parts of the world. This group of disorders has become a vital importance in world health with increasing age of population. 2 Amongst various important etiologies, cardioembolic source remains an important cause for ischaemic stroke. In general, about 20% of ischaemic strokes are caused by large vessel atherosclerosis (including the aortic arch, intracranial or extra-cranial large arteries), 20% by small vessel disease, 30% by cardioembolism, 5% by miscellaneous causes (e.g. carotid artery dissection), and 25% are of undetermined aetiology. 3,,4,5 Cardioembolic strokes are probably over-represented because finding of a potential source of embolus does not necessarily mean that a stroke is embolic. 6 Atrial arrhythmias, congestive heart failure with low ejection fraction, and akinetic regions are most common sources of brain embolism. The incidence of stroke is inversely proportional to ejection fraction (EF). 7, 8 Conditions that affect endocardium and myocardium promote the formation of cardiac mural thrombi. Mural thrombus formation and embolism are commonest in dilated cardiomyopathy. In this group of patients, mural thrombi form mostly within the trabeculae carneae near the cardiac apex. 9 Because of limited scientific evidences, managing patients with stroke with clot in the heart remains a big challenge. Treatment of patient with brain embolism is directed to open the occluded vessels by the use of drugs that lyse clots or use devices to extract thromboemboli. 9 The decision to use heparin acutely to prevent the next thrombo-embolic event should depend on weighing the risk of acute re-embolization versus the risk of hemorrhage (eg. large infarct size) related to heparin therapy. Heparin does not lyse the existing thrombi although cardiac clots often disappear during heparin treatment. Acute heparinization in MI with mural thrombi is probably warranted but there is lack of evidence to support its use acutely in chronic congestive cardiac failure with mural thrombus. Direct thrombin inhibitors like dabigatran might change the method and risk of anticoagulation. 9 Anticoagulant treatment is reasonable for chronic prophylactic treatment to prevent re-embolization in patients with cardiomyopathy with intraventricular thrombi but controversy exists in the use of warfarin in patients with low ejection fraction without thrombus.
Current recommendation for patients with ischaemic stroke or TIA who have dilated cardiomyopathy, either warfarin (INR of 2.0 to 3.0) or antiplatelet therapy may be considered for prevention of recurrent events (Class IIb, Level of Evidence C). 10 To conclude, stroke as a result of ventricular thrombus secondary to dilated cardiomyopathy should be managed carefully considering the extent of cerebral ischemia, cardiac status, and present recommendation (although weak and of low level evidence).
Learning points 1. Murmur may not be appreciated clinically in patients with low ejection fraction. 2. Left ventricular thrombus in stroke patients should be treated acutely with heparin weighing the risk benefit ratio. 3. Oral anticoagulation may be better option for long term management to prevent re-embolization in dilated cardiomyopathy.
